Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06569823
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine Z-1018 Compared to Shingrix in Healthy Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 12 Randomized Observer-Blinded Active-Controlled Dose Escalation Multicenter Trial to Evaluate the Safety Tolerability and Immunogenicity of an Investigational Herpes Zoster Vaccine Z-1018 Compared to Shingrix in Healthy Adults
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized active-controlled observer-blinded dose-escalation multi-center trial of 2 doses of an investigational HZ vaccine Z-1018 in approximately 440 healthy adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None